Susquehanna International Group
OPXAW

Susquehanna International Group’s Opexa Therapeutics, Inc. OPXAW Stock Holding History

Susquehanna International Group’s Portfolio OPXAW Stock Details OPXAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-256,572
Closed -$4K – 10309
2017
Q1 		$4K Buy
+256,572
New +$4.72K ﹤0.01% 8799
2016
Q4 		– Sell
-18,596
Closed -$2K – 10522
2016
Q3 		$2K Buy
+18,596
New +$1.7K ﹤0.01% 8320

Other funds holding OPXAW

VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Susquehanna International Group's OPXAW Position: Q2 2017 in Review

Susquehanna International Group sold out of Opexa Therapeutics, Inc. (OPXAW) in Q2 2017, closing a stake of 256,572 shares — an estimated $4K sold.

Susquehanna International Group first reported a position in OPXAW in Q3 2016 and held it in 2 quarters. The position peaked at $4K in Q1 2017. 4 funds tracked by Wall St. Rank hold OPXAW as of Q2 2017.

  • Susquehanna International Group reported no remaining Opexa Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Susquehanna International Group sold 256,572 Opexa Therapeutics, Inc. shares in Q2 2017, an estimated $4K.
  • Susquehanna International Group first reported a position in Opexa Therapeutics, Inc. in Q3 2016 and held it in 2 quarters.
  • Susquehanna International Group's Opexa Therapeutics, Inc. position peaked at $4K in Q1 2017.
  • 4 funds tracked by Wall St. Rank held Opexa Therapeutics, Inc. as of Q2 2017.

Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.